2018
DOI: 10.3389/fmolb.2018.00086
|View full text |Cite
|
Sign up to set email alerts
|

The Role of PI3K in Met Driven Cancer: A Recap

Abstract: The Receptor Tyrosine Kinase (RTK) Met, overexpressed or mutated in cancer, plays a major role in cancer progression and represents an attractive target for cancer therapy. However RTK inhibitors can lead to drug resistance, explaining the necessity to develop therapies that target downstream signaling. Phosphatidylinositide 3-kinase (PI3K) is one of the most deregulated pathways in cancer and implicated in various types of cancer. PI3K signaling is also a major signaling pathway downstream of RTK, including M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
33
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(34 citation statements)
references
References 118 publications
(158 reference statements)
1
33
0
Order By: Relevance
“…The pathways with downregulated expression of DEmRNAs included the JAK‐STAT signaling pathway and MAPK signaling pathway, which were previously found to be associated with malignant tumors . The PI3K‐Akt signaling pathway has been shown to participate in cell proliferation, migration, differentiation, survival, and trafficking in vitro …”
Section: Discussionmentioning
confidence: 95%
“…The pathways with downregulated expression of DEmRNAs included the JAK‐STAT signaling pathway and MAPK signaling pathway, which were previously found to be associated with malignant tumors . The PI3K‐Akt signaling pathway has been shown to participate in cell proliferation, migration, differentiation, survival, and trafficking in vitro …”
Section: Discussionmentioning
confidence: 95%
“…Proteins that express a proto-oncogene tyrosine-protein kinase (Src) homology domain 2 (SH2) region bind to the activated receptor, areactivated, and forward the signal to the downstream effectors, propagating critical cellular signaling pathways [ 45 ]. EGFR can simultaneously activate several signal transduction pathways such as phosphatidylinositide 3 kinase (PI3K) and serine–threonine kinase (AKT) and RAS/MAPK pathways [ 46 ].…”
Section: Mechanisms Of Egfr Pathway Activationmentioning
confidence: 99%
“…Intriguingly, one of the genes, Gtpbp1, promotes degradation of target mRNA species and plays a role in the regulation of circadian mRNA stability 57 . In some cases, a link with pacemaking can be speculated on: Met is a transcript for a receptor tyrosine kinase, which is known to target phosphoinositide 3-kinase 58 , which in turn is known to target HCN4 31 . Ephb4 is a transcript for another receptor tyrosine kinase, and could it act in a similar way?…”
Section: Metabolismmentioning
confidence: 99%